Gubaeva D N, Melikyan M A, Ryzhkova D V, Poyda M D, Bairov V G, Sukhotskaya A A, Sokolov Y Y, Efremenkov A M, Mitrofanova L B, Christesen H, Nikitina I L
Endocrinology Research Certre.
Almazov National Medical Research Center.
Probl Endokrinol (Mosk). 2019 Nov 23;65(5):319-329. doi: 10.14341/probl10317.
Congenital hyperinsulinism (CHI) is a severe disease with a high risk of complications including neurological deficit. Persistent hypoglycemia in patients with focal form of CHI can not be managed with medical treatment in 96.4% of cases, what subsequently leads to surgical treatment. Currently, there is a lack of information regarding patients with focal form of CHI. This study is aimed at finding better approaches for diagnosis and treatment of patients with focal form of CHI.
To study clinical, genetic and PET/CT findings of the focal form of CHI in Russian group of patients.
The observational research included all patients with a histologically confirmed focal form of CHI, who were admitted to Endocrinology Research Centre during the period from January 2008 to January 2019. A statistical analysis of clinical data, genotype, and positron emission tomography (PET) with 18F-dihydroxyphenylalanine (18F-DOPA) was performed. The median follow-up was 18 months.
The study included 31 patients with focal CHI (14 boys, 45.2%). All patients had a neonatal presentation of the disease and demanded high levels of continuous glucose infusion to maintain euglycemia. The difference between the age of hypoglycemia presentation and the age of diagnosis ranged from 1 day to 3.9 months. In all cases, diazoxide was found to be ineffective. However, in 9 patients, it was possible to withdraw continuous glucose infusion and maintain euglycemia using octreotide in the preoperative period. A molecular genetic study allowed us to detect diverse pathogenic variants in ABCC8 and KCNJ11 genes in 30 patients. According to PET data with 18F-DOPA, the pancreatic index (PI) varied widely from 1.16 to 3.59. After partial resection of the pancreatic region with insulin hypersecretion, all patients showed complete recovery.
The focal form of CHI is a severe condition with high prevalence of neurological complications. For preoperative diagnosis of the morphological form of the disease, it is necessary to conduct genetic analysis and radionuclide studies. Solely evaluation of mathematical parameters in 18F-DOPA PET without taking into account the visual data and the results of genetic analysis does not allow establishing the robust diagnosis. Timely diagnosis, identification of risk factors, and prevention of complications of persistent hypoglycemia are important tasks for clinicians.
先天性高胰岛素血症(CHI)是一种严重疾病,具有包括神经功能缺损在内的高并发症风险。局灶型CHI患者中,96.4%的病例无法通过药物治疗控制持续性低血糖,这随后导致手术治疗。目前,关于局灶型CHI患者的信息匮乏。本研究旨在寻找局灶型CHI患者更好的诊断和治疗方法。
研究俄罗斯患者组中局灶型CHI的临床、遗传和PET/CT表现。
观察性研究纳入了2008年1月至2019年1月期间入住内分泌研究中心、组织学确诊为局灶型CHI的所有患者。对临床数据、基因型以及用18F-二羟基苯丙氨酸(18F-DOPA)进行的正电子发射断层扫描(PET)进行了统计分析。中位随访时间为18个月。
该研究纳入了31例局灶型CHI患者(14例男孩,占45.2%)。所有患者均在新生儿期发病,需要高水平的持续葡萄糖输注以维持血糖正常。低血糖出现年龄与诊断年龄之间的差异为1天至3.9个月。在所有病例中,发现二氮嗪无效。然而,在9例患者中,术前使用奥曲肽有可能停止持续葡萄糖输注并维持血糖正常。分子遗传学研究使我们在30例患者中检测到ABCC8和KCNJ11基因中的多种致病变异。根据18F-DOPA的PET数据,胰腺指数(PI)在1.16至3.59之间广泛变化。在部分切除胰岛素分泌过多的胰腺区域后,所有患者均完全康复。
局灶型CHI是一种严重疾病,神经并发症患病率高。对于该疾病形态学类型的术前诊断,有必要进行基因分析和放射性核素研究。仅评估18F-DOPA PET中的数学参数而不考虑视觉数据和基因分析结果,无法做出可靠诊断。及时诊断、识别危险因素以及预防持续性低血糖并发症是临床医生的重要任务。